Comparing Objective Measures of Adherence to HIV Antiretroviral Therapy: Electronic Medication Monitors and Unannounced Pill Counts (original) (raw)
REFERENCES
Arnet, I., and Haefeli, W. E. (2000). Overconsumption detected by electronic drug monitoring requires subtle interpretation. Clinical Pharmacology and Therapeutics, 67, 44–47. Google Scholar
Bangsberg, D. R., Hecht, F. M., Charlebois, E. D., Zolop, A. R., Holodniy, M., Sheiner, L., Bamberger, J. D., Chesney, M. A., and Moss, A. (2000). Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population, AIDS, 14, 357–366. Google Scholar
Bangsberg, D., and Moss, A. (1999).When should we delay highly active antiretroviral therapy? Journal of General Internal Medicine, 14, 446–448. Google Scholar
Bangsberg, D., Tulsky, J. P., Hecht, F. M., and Moss, A. R. (1997). Protease inhibitors in the homeless. JAMA, 278, 63–65. Google Scholar
Craig, H. M. (1985). Accuracy of indirect measures of medication compliance in hypertension, Research in Nursing Health, 8, 61–66. Google Scholar
Descampes, D., Flandre, P., Calvez, V., Petavin, G., Meiffredy, V., Collin, G., Delaugerre, C., Robert-Delmas, S., Bazin, B., Aboulker, J., Pialoux, G., Raffi, F. and Brun-Vezinet, F. (2000). Mechanisms of virologic failure in previously untreated HIV-infected patients from a trial of induction-maintenance therapy, JAMA, 283, 205–211. Google Scholar
Farmer, K. C. (1999). Methods for measuring and monitoring medication regimen adherence in clinical trials and clinical practice, Clinical Therapeutics, 21, 1074–1090; discussion 1073. Google Scholar
Gerbert, B., Abercombie, P., Bronstone, A., Clannon, K., and Bangsberg, D. (2000). Challenges in adherence:The providers' perspective, AIDS Care, 12, 409–421. Google Scholar
Gifford, A. L., Bormann, J. E., Shively, M. J., Wright, B. C., Richman, D. D., and Bozzette, S. A. (2000). Predictors of self-reported adherence and plasma HIV concentrations in patients on multidrug antiretroviral regimens, Journal of Acquired Immune Deficiency Syndrome, 23, 386–395. Google Scholar
Gilbert, J. R., Evans, C. E., Haynes, R. B., and Tugwell, P. (1980). Predicting compliance with a regimen of digoxin therapy in family practice, Canadian Medical Association Journal, 123, 119–122. Google Scholar
Gordis, L., Markowitz, M., and Lilienfeld, A. M. (1969). Studies in the epidemiology and preventability of rheumatic fever. IV. Aquantitative determination of compliance in children on oral penicillin prophylaxis, Pediatrics, 43, 173–182. Google Scholar
Grymonpre, R. E., Didur, C. D., Montgomery, P. R., and Sitar, D. S. (1998). Pill count, self-report, and pharmacy claims data to measure medication adherence in the elderly, Annals of Pharmacotherapy, 32, 749–754. Google Scholar
Haubrich, R. H., Little, S. J., Currier, J. S., Forthal, D. N., Kemper, C. A., Beall, G. N., Johnson, D., Dube, M. P., Hwang, J. Y., and McCutchan, J. A. (1999). The value of patient-reported adherence to antiretroviral therapy in predicting virologic and immunologic response. California Collaborative Treatment Group, AIDS, 13, 1099–1107. Google Scholar
Havlir, D. V., Hellmann, N. S., Petropoulos, C. J., Whitcomb, J. M., Collier, A. C., Hirsch, M. S., Tebas, P., Sommadossi, J. P., and Richman, D. D. (2000). Drug susceptibility in HIV infection after viral rebound in patients receiving indinavir-containing regimens [see comments], JAMA, 283, 229–234. Google Scholar
Inui, T. S., Carter, W. B., and Pecoraro, R. E. (1981). Screening for noncompliance among patients with hypertension: Is self-report the best availablemeasure? Medical Care, 19, 1061–1064. Google Scholar
Kastrissios, H., Suarez, J. R., Katzenstein, D., Girard, P., Sheiner, L. B., and Blaschke, T. F. (1998). Characterizing patterns of drug-taking behavior with a multiple drug regimen in an AIDS clinical trial, AIDS, 12, 2295–2303. Google Scholar
Lee, J. Y., Kusek, J. W., Greene, P. G., Bernhard, S., Norris, K., Smith, D., Wilkening, B., and Wright, J. T., Jr. (1996). Assessing medication adherence by pill count and electronic monitoring in the African American Study of Kidney Disease and Hypertension (AASK) Pilot Study, American Journal of Hypertension, 9, 719–725. Google Scholar
Matsui,D., Hermann, C., Klein, J., Berkovitch, M., Olivieri, N., and Koren, G. (1994). Critical comparison of novel and existing methods of compliance assessment during a clinical trial of an oral iron chelator, Journal of Clinical Pharmacology, 34, 944–949. Google Scholar
Metry, J. M., and Meyer, U. A. (1999). Drug regimen compliance. Chichester, West Sussex: Wiley. Google Scholar
Paes, A. H., Bakker, A., and Soe-Agnie, C. J. (1998). Measurement of patient compliance, Pharmology World Science, 20, 73–77. Google Scholar
Paterson, D. L., Swindells, S., Mohr, J., Brester, M., Vergis, E. N., Squier, C., Wagener, M. M., and Singh, N. (2000). Adherence to protease inhibitor therapy and outcomes in patients with HIV infection, Annals of Internal Medicine, 133, 21–30. Google Scholar
Straka, R. J., Fish, J. T., Benson, S. R., and Suh, J. T. (1997). Patient self-reporting of compliance does not correspond with electronic monitoring: An evaluation using isosorbide dinitrate as a model drug, Pharmacotherapy, 17, 126–132. Google Scholar
Vanhove, G. F., Schapiro, J. M., Winters, M. A., Merigan, T. C., and Blaschke, T. F. (1996). Patient compliance and drug failure in protease inhibitor monotherapy [letter], JAMA, 276, 1955–1956. Google Scholar
Waterhouse, D. M., Calzone, K. A., Mele, C., and Brenner, D. E. (1993). Adherence to oral tamoxifen: a comparison of patient self-report, pill counts, and microelectronic monitoring [see comments], Journal of Clinical Oncology, 11(6), 1189–1197. Google Scholar
Zolopa, A. R., Hahn, J. A., Gorter, R., Miranda, J., Wlodarczyk, D., Peterson, J., Pilote, L., and Moss, A. R. (1994). HIV and tuberculosis infection in San Francisco's homeless adults. Prevalence and risk factors in a representative sample [see comments], JAMA, 272(6), 455–461. Google Scholar